Clinical Trial

Exparel and Education to Avoid Opioids After Carpal Tunnel Release

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2019-03-07; most recent amendment 2026-04-02.
Trial Details
NCT Number NCT03867539
Lead Sponsor Kettering Health Network
Collaborators: American Society for Surgery of the Hand
Conditions Carpal Tunnel Syndrome
Enrollment 64 participants
Start Date 2019-02-15
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-08